Multiple myeloma and immunosecretory disorders: an update

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Immunosecretory disorders involve abnormal immunoglobulin (Ig)-synthesizing B cell proliferation.
• These conditions include multiple myeloma (MM), Waldenstrom macroglobulinemia, and monoclonal Ig deposition diseases.
• Diagnosis has been challenging due to diverse classifications, often relying on morphology.

Purpose of the Study:

• To review the modern classification of immunosecretory disorders.
• To highlight the integration of various parameters for diagnosis and understanding disease progression.
• To address the evolution of classification schemes, including WHO and International Myeloma Group criteria.

Main Methods:

• Review of existing literature and classification systems.
• Integration of clinical, morphologic, laboratory, radiographic, and biologic data.
• Analysis of diagnostic criteria and definitions for immunosecretory disorders.

Main Results:

• Immunosecretory disorders are characterized by monoclonal protein (M-protein) production.
• Previous classifications, primarily morphologic, posed diagnostic challenges.
• The 2003 International Myeloma Group definition clarified MM by linking it to organ damage.

Conclusions:

• Modern classification requires integrating clinical, morphologic, laboratory, radiographic, and biologic parameters.
• Accurate classification is crucial for understanding disease progression and patient outcomes.
• The evolution of classification reflects a move towards a more comprehensive diagnostic approach.